DHA phase i sttr medical research proposal titled: organoid research and automated characterization for live electrophysiology (oracle)
Ended Purchase Order Awarded
- Contract number
- HT942525P0067
- Awardee
-
Sciperio Inc. UEI GKUVEK4HMMZ8
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $249,980
Award facts
- Opportunity
-
- HQ003420RBDST Solicitation number
- Contract value 100% obligated
- $249,979.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 12 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Orlando, FL 32826, USA
- Research
- STTR Phase I
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $250K Small Business Technology Transfer (STTR) Phase I contract to Sciperio Inc., an Orlando-based advanced manufacturing and materials research firm, to develop ORACLE (Organoid Research and Automated Characterization for Live Electrophysiology). This total small business set-aside contract, issued as a firm fixed-price purchase order, will leverage Sciperio's multidisciplinary engineering capabilities to advance biomedical research technologies. The project is scheduled for completion by January 8, 2026, with work performed at the company's Orlando, Florida facility.
Sciperio brings substantial experience executing federal research and development contracts for military and civilian agencies, including NASA, the Department of the Army, and the Air Force Research Laboratory, with demonstrated expertise in advanced manufacturing, electronics development, and biomedical innovation. The company's prior engagement in biomanufacturing projects—including development of 3D bone marrow organoid constructs and bioreactors for hematopoietic stem cell applications—positions it well to execute this organoid characterization research effort, which aligns with the Defense Health Agency's mission to support medical research capabilities for the military health system.
Quick answers
Who was awarded contract HT942525P0067?
HT942525P0067 was awarded to Sciperio Inc. by Defense Health Agency (Department of Defense) on June 9, 2025.
How much is contract HT942525P0067 worth?
The government has obligated $249,980 on HT942525P0067.
Was contract HT942525P0067 competed?
The extent of competition for HT942525P0067 was full and open competition after exclusion of sources. The government received 12 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award